The Minimally Invasive Micro Sclerostomy (MIMS®) System is Intended for the Reduction of Elevated Intraocular Pressure (IOP): The Minimally Invasive Micro Sclerostomy (MIMS®) System is Intended for the Reduction of Elevated Intraocular Pressure (IOP)
Clinical trial NCT07051174 · COMPLETED
Trial details
- NCT number
- NCT07051174
- Sponsor
- Sanoculis Ltd
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2022-04-11
- Primary completion
- 2023-08-30
- Enrollment
- 88
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.